These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 26892533)
1. Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013). Aljundi AHS; Mohammed SFK; Patel A; Singh R; Arabi A; AlBinali HA; Al Suwaidi J BMC Cardiovasc Disord; 2016 Feb; 16():47. PubMed ID: 26892533 [TBL] [Abstract][Full Text] [Related]
2. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144 [TBL] [Abstract][Full Text] [Related]
3. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Galvao M; Kalman J; DeMarco T; Fonarow GC; Galvin C; Ghali JK; Moskowitz RM J Card Fail; 2006 Mar; 12(2):100-7. PubMed ID: 16520256 [TBL] [Abstract][Full Text] [Related]
4. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ; J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636 [TBL] [Abstract][Full Text] [Related]
5. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
6. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure. Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels. Pan HY; Zhu JH; Gu Y; Yu XH; Pan M; Niu HY BMC Cardiovasc Disord; 2014 Mar; 14():31. PubMed ID: 24593826 [TBL] [Abstract][Full Text] [Related]
19. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M; J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579 [TBL] [Abstract][Full Text] [Related]
20. Cardiac troponin and outcome in acute heart failure. Peacock WF; De Marco T; Fonarow GC; Diercks D; Wynne J; Apple FS; Wu AH; N Engl J Med; 2008 May; 358(20):2117-26. PubMed ID: 18480204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]